Shahbazi Hamed bought NAGE
June 24, 2026 · Form 4 insider transaction
Shahbazi Hamed bought 31,746 shares of Niagen Bioscience, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
31,746
Price
$0.00
Total value
N/A
InsiderShahbazi Hamed
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 24, 2026
Filing dateJune 26, 2026
Shares owned after31,746
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Option vests 100% on June 24, 2027.